Chris is a Scientist at Pfizer in the Biomedicine Design Group at Andover Massachusetts. He has over 16 years of assay development experience for a wide array of biotherapeutics, from monoclonal antibodies to oligonucleotides. The developed ligand-binding assays are used to support pre-clinical studies for PK, TK, ADA, and biomarkers. Chris has extensive experience on multiple assay platforms including, Gyrolab, MSD, Singulex Erenna, Quanterix Samoa and Luminex. Prior to joining Pfizer in May of 2000, Chris worked for 5 years at Bayer Diagnostics in a role that bridged instrument engineering design and diagnostic assay development.